The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Underreporting and poor adherence to American Thoracic Society guidelines are common in cases of isoniazid hepatotoxicity and are associated with hospitalization, death, and liver transplantation.187,188”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [188]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
Nglazi, M. D., Bekker, L.-G., Wood, R., Hussey, G. D., & Wiysonge, C. S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-566 · Cited by 119
Research works printed but not linked: 19
- Garibaldi, 1972, Isoniazid-associated hepatitis. Report of an outbreak, Am Rev Respir Dis, 106, 357, 10.1164/arrd.1972.106.3.357 · DOI
- Runyon, 1965, Preventive treatment in tuberculosis: a statement by the Committee on Therapy, American Thoracic Society, Am Rev Respir Dis, 91, 297
- Randolph, 1953, Toxic hepatitis with jaundice occurring in a patient treated with isoniazid, J Am Med Assoc, 152, 38, 10.1001/jama.1953.63690010014007i · DOI
- Gellis, 1955, Hepatitis following isoniazid, Dis Chest, 28, 462, 10.1378/chest.28.4.462 · DOI
- Saukkonen, 2006, An official ATS statement: hepatotoxicity of antituberculosis therapy, Am J Respir Crit Care Med, 174, 935, 10.1164/rccm.200510-1666ST · DOI · Paper page
- Nolan, 1999, Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic, JAMA, 281, 1014, 10.1001/jama.281.11.1014 · DOI · Paper page
- LoBue, 2003, Use of isoniazid for latent tuberculosis infection in a public health clinic, Am J Respir Crit Care Med, 168, 443, 10.1164/rccm.200303-390OC · DOI
- 2010, Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection-United States, 2004-2008, MMWR Morb Mortal Wkly Rep, 59, 224
- Fontana, 2009, Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct, Drug Saf, 32, 55, 10.2165/00002018-200932010-00005 · DOI · Paper page
- Sterling, 2006, The scope and impact of treatment of latent tuberculosis infection in the United States and Canada, Am J Respir Crit Care Med, 173, 927, 10.1164/rccm.200510-1563OC · DOI
- 1993, Severe isoniazid-associated hepatitis–New York, 1991-1993, MMWR Morb Mortal Wkly Rep, 42, 545
- Gayle, 2000, Targeted tuberculin testing and treatment of latent tuberculosis infection, MMWR Morb Mortal Wkly Rep, 49, 1
- Nolan, 2003, Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime, Am J Respir Crit Care Med, 168, 412, 10.1164/rccm.2306004 · DOI
- Mindikoglu, 2009, Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database, Liver Transpl, 15, 719, 10.1002/lt.21692 · DOI
- Pollock, 2012, A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing, Sci Transl Med, 4, 152ra129, 10.1126/scitranslmed.3003981 · DOI · Paper page
- Danielides, 1983, Hepatitis on high dose isoniazid: reintroduction of the drug in severe tuberculous meningitis, Am J Gastroenterol, 78, 378
- Sharma, 2010, Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity, Clin Infect Dis, 50, 833, 10.1086/650576 · DOI
- Mitchell, 1975, Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy, Chest, 68, 181, 10.1378/chest.68.2.181 · DOI
- Mitchell, 1976, Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis, Ann Intern Med, 84, 181, 10.7326/0003-4819-84-2-181 · DOI
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Self-citationAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationComprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Stephens, C., Robles-Diaz, M., Medina-Caliz, I., Garcia-Cortes, M., Ortega-Alonso, A., Sanabria-Cabrera, J., Gonzalez-Jimenez, A., Alvarez-Alvarez, I., Slim, M., Jimenez-Perez, M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.029 · Cited by 148
Self-citationStine, J. G., & Lewis, J. H. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1127756 · Cited by 104
Self-citationDrug-induced liver injury: Highlights from a review of the 2015 literature
Sarges, P., Steinberg, J. M., & Lewis, J. H. (2016) · Drug Safety · doi:10.1007/s40264-016-0427-8 · Cited by 74
Self-citation
Metadata
- Authors
- Hayashi, P. H., Fontana, R. J., Chalasani, N. P., Stolz, A. A., Talwalkar, J. A., Navarro, V. J., Lee, W. M., Davern, T. J., Kleiner, D. E., Gu, J., Hoofnagle, J. H., Chalasani, N., Vuppalanchi, R., Molleston, J., Lumeng, L., Corne, A., Plummer, A., Bonkovsky, H., Protiva, P., Freston, J., Rosson, R., Levine, R. A., Maliakkal, B., Appleton, P., Smialek, M., Fontana, R. J., Conjeevaram, H., Moseley, R., Gordon, S., Welch, S., Worley, J., Kridler, J., Trivedi, S., Kochlar, S., Watkins, P., Hayashi, P. H., Russo, M., Guess, H., Beaver, K., Smith, A., Lewis, J., Pusek, S., Russell, T., Mehltretter, L., Davern, T., Bonacini, M., Partovi, K., Fajardo, K., Tai, S., Lee, W. M., Rockey, D., Larson, A., Grant, L., Landgraf, K., Stoltz, A., Kaplowitz, N., Milstein, S., Talwalker, J., Johnson, S., Navarro, V., Reddy, R., Vega, M., Wirjosemito, A., Evans, K., Rochon, J., McHutchison, J., Tilllmann, H., Maggio, M., Yang, H., Galan, K., Cosslin, E., Sunas, L., Collini, M., Rose, T., Crowder, M., Scharenbroich, C., Rostami, H., Jiezhun, S., Monroe, T., Hammett, A., Rosado, N., Serrano, J., Seeff, L., Hoofnagle, J., Toke, D., Witt, D., Higgins, H., Kleiner, D., Avigan, M., & Senior, J.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 13
- Issue
- 9
- Pages
- 1676-1682.e1
- ISSN
- 1542-3565
- Cited by
- 45
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.